{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:30:00Z","timestamp":1793244600245,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,11,13]],"date-time":"2012-11-13T00:00:00Z","timestamp":1352764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00401-012-1061-x","type":"journal-article","created":{"date-parts":[[2012,11,12]],"date-time":"2012-11-12T01:16:40Z","timestamp":1352683000000},"page":"809-821","source":"Crossref","is-referenced-by-count":35,"title":["APP mutations in the A\u03b2 coding region are associated with abundant cerebral deposition of A\u03b238"],"prefix":"10.1007","volume":"124","author":[{"given":"Maria Luisa","family":"Moro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Giaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Indaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Uggetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Morbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Saccucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Di Fede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Catania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic M.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Demarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Rozemuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenad","family":"Bogdanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orso","family":"Bugiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardino","family":"Ghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Tagliavini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,13]]},"reference":[{"key":"1061_CR1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00401-008-0358-2","volume":"115","author":"I Alafuzoff","year":"2008","unstructured":"Alafuzoff I, Pikkarainen M, Arzberger T et al (2008) Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortium. Acta Neuropathol 115:533\u2013546","journal-title":"Acta Neuropathol"},{"key":"1061_CR2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/archneur.65.4.499","volume":"65","author":"H Basun","year":"2008","unstructured":"Basun H, Bogdanovic N, Ingelsson M et al (2008) Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease. Arch Neurol 65:499\u2013505","journal-title":"Arch Neurol"},{"key":"1061_CR3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1471-4159.2005.03578.x","volume":"96","author":"M Bentahir","year":"2006","unstructured":"Bentahir M, Nyabi O, Verhamme J et al (2006) Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. J Neurochem 96:732\u2013742","journal-title":"J Neurochem"},{"key":"1061_CR4","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1093\/hmg\/ddq142","volume":"19","author":"K Bettens","year":"2010","unstructured":"Bettens K, Sleegers K, Van Broeckhoven C (2010) Current status on Alzheimer disease molecular genetics: from past, to present, to future. Hum Mol Genet 19:R4\u2013R11","journal-title":"Hum Mol Genet"},{"key":"1061_CR5","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1212\/WNL.0b013e3181d52785","volume":"74","author":"AC Bruni","year":"2010","unstructured":"Bruni AC, Bernardi L, Colao R et al (2010) Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutation. Neurology 74:798\u2013806","journal-title":"Neurology"},{"key":"1061_CR6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","volume":"69","author":"P Buchhave","year":"2012","unstructured":"Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, Hansson O (2012) Cerebrospinal fluid levels of \u03b2-amyloid 1\u201342, but not of tau, are fully changed already 5 to 10\u00a0years before the onset of Alzheimer dementia. Arch Gen Psychiatry 69:98\u2013106","journal-title":"Arch Gen Psychiatry"},{"key":"1061_CR7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/archneurol.2010.178","volume":"67","author":"O Bugiani","year":"2010","unstructured":"Bugiani O, Giaccone G, Rossi G et al (2010) Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP. Arch Neurol 67:987\u2013995","journal-title":"Arch Neurol"},{"key":"1061_CR8","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/emboj.2012.79","volume":"31","author":"L Ch\u00e1vez-Guti\u00e9rrez","year":"2012","unstructured":"Ch\u00e1vez-Guti\u00e9rrez L, Bammens L, Benilova I et al (2012) The mechanism of \u03b3-secretase dysfunction in familial Alzheimer disease. EMBO J 31:2261\u20132274","journal-title":"EMBO J"},{"key":"1061_CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/JAD-2010-1205","volume":"19","author":"C Cupidi","year":"2010","unstructured":"Cupidi C, Capobianco R, Goffredo D et al (2010) Neocortical variation of A\u03b2 load in fully expressed, pure Alzheimer disease. J Alzheimer Dis 19:57\u201368","journal-title":"J Alzheimer Dis"},{"key":"1061_CR10","doi-asserted-by":"crossref","first-page":"17049","DOI":"10.1074\/jbc.M802912200","volume":"283","author":"E Czirr","year":"2008","unstructured":"Czirr E, Cottrell BA, Leuchtenberger S et al (2008) Independent generation of Abeta42 and Abeta38 peptide species by gamma-secretase. J Biol Chem 283:17049\u201317054","journal-title":"J Biol Chem"},{"key":"1061_CR11","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M201750200","volume":"277","author":"KN Dahlgren","year":"2002","unstructured":"Dahlgren KN, Manelli AM, Stine WB Jr, Baker LK, Krafft GA, LaDu MJ (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 277:32046\u201332053","journal-title":"J Biol Chem"},{"key":"1061_CR12","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1126\/science.1168979","volume":"323","author":"G Fede Di","year":"2009","unstructured":"Di Fede G, Catania M, Morbin M et al (2009) A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science 323:1473\u20131477","journal-title":"Science"},{"key":"1061_CR13","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","volume":"9","author":"B Dubois","year":"2010","unstructured":"Dubois B, Feldman HH, Jacova C et al (2010) Revising the definition of Alzheimer\u2019s disease: a new lexicon. Lancet Neurol 9:1118\u201311127","journal-title":"Lancet Neurol"},{"key":"1061_CR14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-007-0312-8","volume":"115","author":"C Duyckaerts","year":"2008","unstructured":"Duyckaerts C, Potier MC, Delatour B (2008) Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol 115:5\u201338","journal-title":"Acta Neuropathol"},{"key":"1061_CR15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3233\/JAD-2011-110185","volume":"25","author":"M Gallo","year":"2011","unstructured":"Gallo M, Marcello N, Curcio SA et al (2011) A novel pathogenic PSEN1 mutation in a family with Alzheimer\u2019s disease: phenotypical and neuropathological features. J Alzheimers Dis 25:425\u2013431","journal-title":"J Alzheimers Dis"},{"key":"1061_CR16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1474-4422(11)70055-2","volume":"10","author":"G Giaccone","year":"2011","unstructured":"Giaccone G, Arzberger T, Alafuzoff I et al (2011) BrainNet Europe consortium. New lexicon and criteria for the diagnosis of Alzheimer\u2019s disease. Lancet Neurol. 10:298\u2013299","journal-title":"Lancet Neurol."},{"key":"1061_CR17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-010-0747-1","volume":"120","author":"G Giaccone","year":"2010","unstructured":"Giaccone G, Morbin M, Moda F et al (2010) Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features. Acta Neuropathol 120:803\u2013812","journal-title":"Acta Neuropathol"},{"key":"1061_CR18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0304-3940(89)90169-9","volume":"97","author":"G Giaccone","year":"1989","unstructured":"Giaccone G, Tagliavini F, Linoli G et al (1989) Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci Lett 97:232\u2013238","journal-title":"Neurosci Lett"},{"key":"1061_CR19","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Tung YC et al (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci 83:4913\u20134917","journal-title":"Proc Natl Acad Sci"},{"key":"1061_CR20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuint.2009.03.007","volume":"55","author":"E Hellstr\u00f6m-Lindah","year":"2009","unstructured":"Hellstr\u00f6m-Lindah E, Viitanen M, Marutle A (2009) Comparison of Abeta levels in the brain of familial and sporadic Alzheimer\u2019s disease. Neurochem Int 55:243\u2013252","journal-title":"Neurochem Int"},{"key":"1061_CR21","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","volume":"32","author":"JT Jarrett","year":"1993","unstructured":"Jarrett JT, Berger EP, Lansbury PT Jr (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer\u2019s disease. Biochemistry 32:4693\u20134697","journal-title":"Biochemistry"},{"key":"1061_CR22","doi-asserted-by":"crossref","first-page":"39804","DOI":"10.1074\/jbc.M111.274696","volume":"286","author":"TL Kukar","year":"2011","unstructured":"Kukar TL, Ladd TB, Robertson P et al (2011) Lysine 624 of the amyloid precursor protein (APP) is a critical determinant of amyloid \u03b2 peptide length: support for a sequential model of \u03b3-secretase intramembrane proteolysis and regulation by the amyloid \u03b2 precursor protein (APP) juxtamembrane region. J Biol Chem 286:39804\u201339812","journal-title":"J Biol Chem"},{"key":"1061_CR23","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/humu.20336","volume":"27","author":"S Kumar-Singh","year":"2006","unstructured":"Kumar-Singh S, Theuns J, Van Broeck B et al (2006) Mean age-of-onset of familial Alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40. Hum Mutat 27:686\u2013695","journal-title":"Hum Mutat"},{"key":"1061_CR24","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.2111584","volume":"248","author":"E Levy","year":"1990","unstructured":"Levy E, Carman MD, Fernandez-Madrid IJ et al (1990) Mutation of the Alzheimer\u2019s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124\u20131126","journal-title":"Science"},{"key":"1061_CR25","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","volume":"155","author":"LF Lue","year":"1999","unstructured":"Lue LF, Kuo YM, Roher AE et al (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease. Am J Pathol 155:853\u2013862","journal-title":"Am J Pathol"},{"key":"1061_CR26","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/pmic.200700311","volume":"7","author":"JM Maler","year":"2007","unstructured":"Maler JM, Klafki HW, Paul S et al (2007) Urea-based two-dimensional electrophoresis of beta-amyloid peptides in human plasma: evidence for novel Abeta species. Proteomics 7:3815\u20133820","journal-title":"Proteomics"},{"key":"1061_CR27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/jnen\/63.3.199","volume":"63","author":"G Marcon","year":"2004","unstructured":"Marcon G, Giaccone G, Cupidi C et al (2004) Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene. J Neuropathol Exp Neurol 63:199\u2013209","journal-title":"J Neuropathol Exp Neurol"},{"key":"1061_CR28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.brainres.2012.02.041","volume":"1450","author":"JM McDonald","year":"2012","unstructured":"McDonald JM, Cairns NJ, Taylor-Reinwald L, Holtzman D, Walsh DM (2012) The levels of water-soluble and triton-soluble A\u03b2 are increased in Alzheimer\u2019s disease brain. Brain Res 1450:138\u2013147","journal-title":"Brain Res"},{"key":"1061_CR29","doi-asserted-by":"crossref","unstructured":"Mc Donald JM, Savva GM, Brayne C et al (2010) Medical Research Council Cognitive Function and Ageing Study. The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. Brain 133:1328\u20131341","DOI":"10.1093\/brain\/awq065"},{"key":"1061_CR30","doi-asserted-by":"crossref","first-page":"21636","DOI":"10.1074\/jbc.M109.088005","volume":"285","author":"LM Munter","year":"2010","unstructured":"Munter LM, Botev A, Richter L et al (2010) Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif. J Biol Chem 285:21636\u201321643","journal-title":"J Biol Chem"},{"key":"1061_CR31","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/sj.emboj.7601616","volume":"26","author":"LM Munter","year":"2007","unstructured":"Munter LM, Voigt P, Harmeier A et al (2007) GxxxG motifs within the amyloid precursorprotein transmembrane sequence are critical for the etiology of Abeta42. EMBO J 26:1702\u20131712","journal-title":"EMBO J"},{"key":"1061_CR32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.1925564","volume":"254","author":"J Murrell","year":"1991","unstructured":"Murrell J, Farlow M, Ghetti B, Benson MD (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer\u2019s disease. Science 254:97\u201399","journal-title":"Science"},{"key":"1061_CR33","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archneur.57.6.885","volume":"57","author":"JR Murrell","year":"2000","unstructured":"Murrell JR, Hake AM, Quaid KA, Farlow MR, Ghetti B (2000) Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene. Arch Neurol 57:885\u2013887","journal-title":"Arch Neurol"},{"key":"1061_CR34","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/ana.20571","volume":"58","author":"L Obici","year":"2005","unstructured":"Obici L, Demarchi A, de Rosa G et al (2005) A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. Ann Neurol 58:639\u2013644","journal-title":"Ann Neurol"},{"key":"1061_CR35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00439-009-0696-8","volume":"126","author":"D Patterson","year":"2009","unstructured":"Patterson D (2009) Molecular genetic analysis of Down syndrome. Hum Genet 126:195\u2013214","journal-title":"Hum Genet"},{"key":"1061_CR36","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1212\/01.wnl.0000310643.53587.87","volume":"70","author":"P Piscopo","year":"2008","unstructured":"Piscopo P, Marcon G, Piras MR et al (2008) A novel PSEN2 mutation associated with a peculiar phenotype. Neurology 70:1549\u20131554","journal-title":"Neurology"},{"key":"1061_CR37","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1212\/01.WNL.0000137048.80666.86","volume":"63","author":"G Rossi","year":"2004","unstructured":"Rossi G, Giaccone G, Maletta R et al (2004) A family with Alzheimer disease and strokes associated with A713T mutation of the APP gene. Neurology 63:910\u2013912","journal-title":"Neurology"},{"key":"1061_CR38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet-Lecrux","year":"2006","unstructured":"Rovelet-Lecrux A, Hannequin D, Raux G et al (2006) APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38:24\u201326","journal-title":"Nat Genet"},{"key":"1061_CR39","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nn.2858","volume":"14","author":"T Saito","year":"2011","unstructured":"Saito T, Suemoto T, Brouwers N et al (2011) Potent amyloidogenicity and pathogenicity of A\u03b243. Nat Neurosci 14:1023\u20131032","journal-title":"Nat Neurosci"},{"key":"1061_CR40","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol Rev 81:741\u2013766","journal-title":"Physiol Rev"},{"key":"1061_CR41","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ncb1104-1054","volume":"6","author":"DJ Selkoe","year":"2004","unstructured":"Selkoe DJ (2004) Cell biology of protein misfolding: the examples of Alzheimer\u2019s and Parkinson\u2019s diseases. Nat Cell Biol 6:1054\u20131061","journal-title":"Nat Cell Biol"},{"key":"1061_CR42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH et al (2008) Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med 14:837\u2013842","journal-title":"Nat Med"},{"key":"1061_CR43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-009-0521-4","volume":"118","author":"C Shepherd","year":"2009","unstructured":"Shepherd C, McCann H, Halliday GM (2009) Variations in the neuropathology of familial Alzheimer\u2019s disease. Acta Neuropathol 118:37\u201352","journal-title":"Acta Neuropathol"},{"key":"1061_CR44","doi-asserted-by":"crossref","first-page":"16488","DOI":"10.1074\/jbc.M801279200","volume":"283","author":"M Shimojo","year":"2008","unstructured":"Shimojo M, Sahara N, Mizoroki T et al (2008) Enzymatic characteristics of I213T mutant presenilin-1\/gamma-secretase in cell models and knock-in mouse brains: familial Alzheimer disease-linked mutation impairs gamma-site cleavage of amyloid precursor protein C-terminal fragment beta. J Biol Chem 283:16488\u201316496","journal-title":"J Biol Chem"},{"key":"1061_CR45","first-page":"452","volume":"145","author":"N Suzuki","year":"1994","unstructured":"Suzuki N, Iwatsubo T, Odaka A, Ishibashi Y, Kitada C, Ihara Y (1994) High tissue content of soluble beta 1\u201340 is linked to cerebral amyloid angiopathy. Am J Pathol 145:452\u2013460","journal-title":"Am J Pathol"},{"key":"1061_CR46","doi-asserted-by":"crossref","first-page":"13042","DOI":"10.1523\/JNEUROSCI.2362-09.2009","volume":"29","author":"M Takami","year":"2009","unstructured":"Takami M, Nagashima Y, Sano Y et al (2009) gamma-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. J Neurosci 29:13042\u201313052","journal-title":"J Neurosci"},{"key":"1061_CR47","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/jnen\/60.12.1137","volume":"60","author":"M Takao","year":"2001","unstructured":"Takao M, Ghetti B, Murrell JR et al (2001) Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures. J Neuropathol Exp Neurol 60:1137\u20131152","journal-title":"J Neuropathol Exp Neurol"},{"key":"1061_CR48","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP et al (1991) Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572\u2013580","journal-title":"Ann Neurol"},{"key":"1061_CR49","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2353\/ajpath.2010.090636","volume":"176","author":"Y Tomidokoro","year":"2010","unstructured":"Tomidokoro Y, Rostagno A, Neubert TA et al (2010) Iowa variant of familial Alzheimer\u2019s disease: accumulation of posttranslationally modified AbetaD23N in parenchymal and cerebrovascular amyloid deposits. Am J Pathol 176:1841\u20131854","journal-title":"Am J Pathol"},{"key":"1061_CR50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2119\/2007-00094.VanVickle","volume":"14","author":"GD Vickle Van","year":"2008","unstructured":"Van Vickle GD, Esh CL, Kokjohn TA et al (2008) Presenilin-1 280Glu\u2192Ala mutation alters C-terminal APP processing yielding longer abeta peptides: implications for Alzheimer\u2019s disease. Mol Med 14:184\u2013194","journal-title":"Mol Med"},{"key":"1061_CR51","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV et al (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535\u2013539","journal-title":"Nature"},{"key":"1061_CR52","doi-asserted-by":"crossref","first-page":"22364","DOI":"10.1074\/jbc.272.35.22364","volume":"272","author":"DM Walsh","year":"1997","unstructured":"Walsh DM, Lomakin A, Benedek GB, Condron MM, Teplow DB (1997) Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem 272:22364\u201322372","journal-title":"J Biol Chem"},{"key":"1061_CR53","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35102591","volume":"414","author":"S Weggen","year":"2001","unstructured":"Weggen S, Eriksen JL, Das P et al (2001) A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414:212\u2013216","journal-title":"Nature"},{"key":"1061_CR54","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1471-4159.2009.06170.x","volume":"110","author":"H Welander","year":"2009","unstructured":"Welander H, Fr\u00e5nberg J, Graff C et al (2009) Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains. J Neurochem 110:697\u2013706","journal-title":"J Neurochem"},{"key":"1061_CR55","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00702-008-0177-6","volume":"116","author":"V Welge","year":"2009","unstructured":"Welge V, Fiege O, Lewczuk P et al (2009) Combined CSF tau, p-tau181 and amyloid-beta 38\/40\/42 for diagnosing Alzheimer\u2019s disease. J Neural Transm 116:203\u2013212","journal-title":"J Neural Transm"}],"updated-by":[{"DOI":"10.1007\/s00401-013-1094-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T00:00:00Z","timestamp":1360627200000}}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-012-1061-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-012-1061-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-012-1061-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T14:05:33Z","timestamp":1562335533000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-012-1061-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,13]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1061"],"URL":"https:\/\/doi.org\/10.1007\/s00401-012-1061-x","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00401-013-1094-9","asserted-by":"object"}]},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,13]]}}}